COMMUNIQUÉS West-GlobeNewswire

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

30/12/2017 - 00:00

CAMBRIDGE, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to [...]

SELLAS Life Sciences Group Successfully Completes Business Combination with Galena Biopharma

29/12/2017 - 22:46

HAMILTON, Bermuda and NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (Nasdaq: SLS ) (SELLAS Inc.) today announced that the proposed merger of the businesses of SELLAS Life Sciences Group [...]

Edge's EG-1962 Phase 3 NEWTON 2 Study Continues as Planned Following Completion of Futility Analysis

29/12/2017 - 22:05

BERKELEY HEIGHTS, N.J., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Edge Therapeutics, Inc. (Nasdaq: EDGE ), a clinical-stage biotechnology company developing novel hospital-based therapies for the management of acute, life- [...]

Bio-Path Holdings Provides Clinical Update and 2018 Business Outlook

29/12/2017 - 22:01

HOUSTON, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH ), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]

Medovex Corporation Converts IDE Submission to a Pre-Submission with Food and Drug Administration for its DenerveX System

29/12/2017 - 22:00

ATLANTA, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief of Facet Joint Syndrome [...]

ContraVir Pharmaceuticals Announces John Sullivan-Bolyai, M.D., MPH Steps Down as Chief Medical Officer

29/12/2017 - 22:00

EDISON, N.J., Dec. 29, 2017 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), announced today that John Sullivan-Bolyai will step down as Chief Medical Officer and take on a new role in the company, [...]

United American Healthcare Corporation’s Subsidiaries show strong Third Quarter Fiscal Year 2017 Results

29/12/2017 - 21:24

CHICAGO, Dec. 29, 2017 (GLOBE NEWSWIRE) -- United American Healthcare Corporation (the “Company”), today announced that it plans to release its consolidated financial operational results for the three and nine months [...]

Repligen To Present at 36th Annual J.P. Morgan Healthcare Conference

29/12/2017 - 19:47

WALTHAM, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN ), a leading bioprocessing-focused company delivering technology innovation to improve biologic drug manufacturing flexibility and [...]

Veloxis Pharmaceuticals Announces Financial Calendar for 2018

29/12/2017 - 18:13

Company Release no. 26/2017 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 29 December 2017 Veloxis Pharmaceuticals Announces Financial Calendar for 2018 Veloxis Pharmaceuticals A/S today announced its financial [...]

Medtronic Chairman and CEO Omar Ishrak to Speak at J.P. Morgan Healthcare Conference

29/12/2017 - 17:01

DUBLIN - December 29, 2017 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced it will participate in the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018, in [...]

Saniona AB: Saniona Establish Equity Financing of up to SEK 144 million

29/12/2017 - 16:35

PRESS RELEASE December 29, 2017 Saniona AB, a leading biotech company in the field of ion channels, announced today that it has entered into a convertible notes funding agreement with Nice & Green S.A. Under the [...]

Canada House Wellness Group Announces The Retirement of Interim CEO Gerry Goldberg

29/12/2017 - 15:52

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) announces [...]

Galena Biopharma, Inc. Stockholders Approve Business Combination with SELLAS Life Sciences Group, Ltd; Board Sets Reverse Stock Split Ratio

29/12/2017 - 15:25

SAN RAMON, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE ) (“Galena”) announced today that its stockholders approved nine proposals at the reconvened Special Meeting of Stockholders held [...]

Alpha Pro Tech, Ltd. Names Lloyd Hoffman as President; Appoints Donna Millar to Board of Directors

29/12/2017 - 14:50

NOGALES, Ariz., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective [...]

Delcath Announces Exit from Convertible Note

29/12/2017 - 14:35

NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces on December 28, 2017, it [...]

Progenics Pharmaceuticals Announces FDA Acceptance of New Drug Application for AZEDRA® (iobenguane I 131) in Pheochromocytoma and Paraganglioma

29/12/2017 - 14:30

NEW YORK, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced [...]

Hemispherx Biopharma, Inc. to Present at Biotech Showcase™ 2018

29/12/2017 - 14:30

ORLANDO, Fla., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB), focused on pharmaceutical research, today announced, that it will be presenting at the Biotech Showcase™ 2018. The conference [...]

Abiomed to Present at the 36th Annual J.P. Morgan Healthcare Conference

29/12/2017 - 14:00

DANVERS, Mass., Dec. 29, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc . (NASDAQ: ABMD ), a leading provider of breakthrough heart support technologies, today announced that Michael R. Minogue, Chairman, President and Chief [...]

Albireo Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

29/12/2017 - 14:00

BOSTON, Dec. 29, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO ), a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced the grant to two employees [...]